TNFRSF8 and diffuse large B-cell lymphoma: A previous research conducted at Dr. Sardjito General Hospital found that the results of positive CD30 expression in DLBCL with a cut-off of >0% and >20% were 13.5% and 1.9%, respectively, of 104 samples, while other studies found results of 16% and 6%, respectively, of 50 samples [13].